Andrew D. Tran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrew D. Tran has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Joana M. Mack
Arkansas Children's Hospital Little Rock Arkansas USA
2 shared publications- Aaron Mullane
Texas Tech University Health Sciences Center, 1400 S. Coulter Street, Amarillo, TX 79106, USA
1 shared publication Abdelrahman Masri
Arkansas Children's Hospital Little Rock Arkansas USA
1 shared publication- Adam Paul Yan
Division of Hematology/Oncology, The Hospital for Sick Children University of Toronto Toronto Ontario Canada
1 shared publication Ajay Perumbeti
University of Arizona College of Medicine–Phoenix Phoenix Arizona USA
1 shared publicationAlexandra Borst
Department of Pediatrics, The University of North Carolina, UNC Children's Hospital, Chapel Hill, NC
1 shared publication
Latest Publications
- Open Access
- 20 November 2026
- Published by Wiley in Pediatric Blood & Cancer
From Data to Duty: An Informatics Blueprint for Pediatric Oncology Trials
The data generated by cooperative‐group clinical trials have transformed outcomes for children with cancer, yet the infrastructure underlying their collection and use has not kept pace with advances in informatics and data science. Data collection on pediatric oncology trials remains largely manual: Clinical research assistants abstract values from medical records and key them into electronic case report forms, a process that is costly, slow, inconsistent, and error‐prone. Data are often siloed within trial networks for years after a study closes, limiting their value for secondary research, particularly for rare cancers. In this consensus blueprint, an interdisciplinary group of pediatric oncologists, clinical informaticians, data scientists, nurses, clinical research assistants, drug developers, and parent advocates outlines a pragmatic path forward across three components of the data lifecycle: collection, processing, and sharing. We argue that case report forms should be bound to standardized common data elements; that automated data abstraction from electronic health records, including via large language models with human‐in‐the‐loop validation, should replace much of today's manual abstraction; that paper chemotherapy roadmaps should be reconceived as computable artifacts; and that clinical trials data should be deposited in publicly accessible repositories with appropriate governance as soon as practically feasible. We discuss facilitators and barriers within each component, including standards adoption, regulatory complexity, financial sustainability, and workforce capacity. We propose concrete actions for funders, clinical trials networks, professional societies, and industry. The technology to achieve these goals exists today, and widespread adoption requires coordinated leadership, sustainable funding models, and a cultural shift that recognizes data stewardship as an ethical imperative and a duty to the children and families we serve.
- 20 November 2026
- Published by Wiley in Pediatric Blood & Cancer
Open AccessFrom Data to Duty: An Informatics Blueprint for Pediatric Oncology Trials
The data generated by cooperative‐group clinical trials have transformed outcomes for children with cancer, yet the infrastructure underlying their collection and use has not kept pace with advances in informatics and data science. Data collection on pediatric oncology trials remains largely manual: Clinical research assistants abstract values from medical records and key them into electronic case report forms, a process that is costly, slow, inconsistent, and error‐prone. Data are often siloed within trial networks for years after a study closes, limiting their value for secondary research, particularly for rare cancers. In this consensus blueprint, an interdisciplinary group of pediatric oncologists, clinical informaticians, data scientists, nurses, clinical research assistants, drug developers, and parent advocates outlines a pragmatic path forward across three components of the data lifecycle: collection, processing, and sharing. We argue that case report forms should be bound to standardized common data elements; that automated data abstraction from electronic health records, including via large language models with human‐in‐the‐loop validation, should replace much of today's manual abstraction; that paper chemotherapy roadmaps should be reconceived as computable artifacts; and that clinical trials data should be deposited in publicly accessible repositories with appropriate governance as soon as practically feasible. We discuss facilitators and barriers within each component, including standards adoption, regulatory complexity, financial sustainability, and workforce capacity. We propose concrete actions for funders, clinical trials networks, professional societies, and industry. The technology to achieve these goals exists today, and widespread adoption requires coordinated leadership, sustainable funding models, and a cultural shift that recognizes data stewardship as an ethical imperative and a duty to the children and families we serve.
- 29 July 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (9) , e70455
Cerebrovascular Accidents are Associated With Increased Rates of Anxiety and Depression in People With Sickle Cell Disease: A National Database Study
Background: Anxiety and depression are common yet often underrecognized comorbidities in people with sickle cell disease (PwSCD), contributing to poor quality of life and adverse health outcomes. However, few large‐scale studies have examined whether cerebrovascular accident (CVA)—a major complication of SCD—is associated with higher rates of anxiety and depression. Understanding this relationship is essential to inform early screening and comprehensive, multidisciplinary care for PwSCD. Methods: This retrospective cohort study utilized the Epic Cosmos database, which includes over 200 million patients from 1118 US health systems (January 2003–December 2022). Cases were defined as PwSCD aged 0–110 years with a documented history of CVA; controls were PwSCD without CVA. Depression and anxiety were identified using ICD‐10 diagnostic codes. Rates between groups were compared using chi‐square tests with Yates’ correction and Bonferroni adjustment ( p ≤ 0.0083). Results: Among 130,148 PwSCD, 9,306 (7.1%) had a history of CVA. Anxiety and depression were significantly more prevalent in PwSCD with CVA (36.4% and 39.7%) than those without (18.3% and 22.0%; p < 0.0083). Females with CVA had higher rates of both conditions (42.3% and 46.2%) than males (28.5% and 30.9%). The largest proportion of patients with anxiety and depression was in the 50–64‐year age group. Conclusion: PwSCD with a history of CVA are nearly twice as likely to have anxiety and depression as those without. These findings underscore the need for routine anxiety and depression screening and integration of psychosocial care into comprehensive SCD management to improve long‐term outcomes and quality of life.
- 29 July 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (9) , e70455
Cerebrovascular Accidents are Associated With Increased Rates of Anxiety and Depression in People With Sickle Cell Disease: A National Database Study
Background: Anxiety and depression are common yet often underrecognized comorbidities in people with sickle cell disease (PwSCD), contributing to poor quality of life and adverse health outcomes. However, few large‐scale studies have examined whether cerebrovascular accident (CVA)—a major complication of SCD—is associated with higher rates of anxiety and depression. Understanding this relationship is essential to inform early screening and comprehensive, multidisciplinary care for PwSCD. Methods: This retrospective cohort study utilized the Epic Cosmos database, which includes over 200 million patients from 1118 US health systems (January 2003–December 2022). Cases were defined as PwSCD aged 0–110 years with a documented history of CVA; controls were PwSCD without CVA. Depression and anxiety were identified using ICD‐10 diagnostic codes. Rates between groups were compared using chi‐square tests with Yates’ correction and Bonferroni adjustment ( p ≤ 0.0083). Results: Among 130,148 PwSCD, 9,306 (7.1%) had a history of CVA. Anxiety and depression were significantly more prevalent in PwSCD with CVA (36.4% and 39.7%) than those without (18.3% and 22.0%; p < 0.0083). Females with CVA had higher rates of both conditions (42.3% and 46.2%) than males (28.5% and 30.9%). The largest proportion of patients with anxiety and depression was in the 50–64‐year age group. Conclusion: PwSCD with a history of CVA are nearly twice as likely to have anxiety and depression as those without. These findings underscore the need for routine anxiety and depression screening and integration of psychosocial care into comprehensive SCD management to improve long‐term outcomes and quality of life.
- Open Access
- 6 October 2025
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3 (1) , 100112
Impact of anticoagulation on quality of life in patients with slow-flow vascular malformations
- 6 October 2025
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3 (1) , 100112
Open AccessImpact of anticoagulation on quality of life in patients with slow-flow vascular malformations
- Open Access
- 25 August 2016
- Published by Wiley in Journal of Skin Cancer
- Vol. 2016, 1-4
Gender-Based Differences and Barriers in Skin Protection Behaviors in Melanoma Survivors
Purpose. Skin protection behaviors and environmental exposure play a crucial role in the development and subsequent management of melanoma. This study investigates gender-based differences in skin protection behaviors after melanoma treatment.Methods. Patients diagnosed and surgically treated for cutaneous melanomas over the last six years in a geographically high risk area were surveyed over telephone using a standardized script.Results. Of 150 survey results obtained, there were 82 males and 68 females. Overall, 87% of participants reported skin self-examination for abnormal markings more often and 94% reported wearing skin protective clothing more often, with females being more than males. Females limited outdoor activity more often than males, 79% to 54%,. When outside, females sought shade more often than males, 75% to 56%,. However, males wore a wide brim hat more often than females, 52% to 28%,. Interestingly, 60% of participants reported wearing SPF 30 sunscreen less often,.Conclusion. Larger percentage of females adopted behavioral changes to prevent future melanoma. Those living in high risk areas and with outdoor occupations need particular attention to skin care. Population based screening should be adopted to deal with this rising public health crisis.- 25 August 2016
- Published by Wiley in Journal of Skin Cancer
- Vol. 2016, 1-4
Open AccessGender-Based Differences and Barriers in Skin Protection Behaviors in Melanoma Survivors
Purpose. Skin protection behaviors and environmental exposure play a crucial role in the development and subsequent management of melanoma. This study investigates gender-based differences in skin protection behaviors after melanoma treatment.Methods. Patients diagnosed and surgically treated for cutaneous melanomas over the last six years in a geographically high risk area were surveyed over telephone using a standardized script.Results. Of 150 survey results obtained, there were 82 males and 68 females. Overall, 87% of participants reported skin self-examination for abnormal markings more often and 94% reported wearing skin protective clothing more often, with females being more than males. Females limited outdoor activity more often than males, 79% to 54%,. When outside, females sought shade more often than males, 75% to 56%,. However, males wore a wide brim hat more often than females, 52% to 28%,. Interestingly, 60% of participants reported wearing SPF 30 sunscreen less often,.Conclusion. Larger percentage of females adopted behavioral changes to prevent future melanoma. Those living in high risk areas and with outdoor occupations need particular attention to skin care. Population based screening should be adopted to deal with this rising public health crisis.